Autoimmune Disease Outcomes of Women with Breast Implants: A Population-Based Study https://t.co/Z6R8zRezfN #breastimplants #IMID an old chestnut

• Autoimmune Disease Outcomes of Women with Breast Implants: A Population-Based S…

The Use of Tocilizumab and Tofacitinib in Patients with Resolved Hepatitis B Infection: A Case Series https://t.co/2OBy0lxd6b #hepb #tocilizumab #tofacitinib no reactivation in resolved infection

• The Use of Tocilizumab and Tofacitinib in Patients with Resolved Hepatitis B In…

This is referring to Dr Dan Kastner https://t.co/3yQIUCcnAu

• https://twitter.com/esloanmd/status/1325206018133913601

@RichardPAConway @DrDDRheum @DrErickZamora1 @hoffmann_vold @RheumNow YES! Why? 'Normal' echo in 1/3 of patients with early PAH. Screening# Diagnosis. Below is data where echo and RHC was done at the same time. in those with eRVSP < 36, 36% had RHC- derived PAH. https://t.co/W2YiyZnwwV

@DrDDRheum @DrErickZamora1 @hoffmann_vold If you have a normal HRCT and echo does a PFT at same time point add anything? Issues with getting PFTs in covid times #ACR20 @rheumnow @sclerodermaUM

This single slide tries to summarise all major phase3 clinical trials in Psoriatic Arthritis 💪 Take your time. The top half looks at joint efficacy. The bottom half for skin efficacy. #ACR20 https://t.co/FXhJunXNKt

Reducing Immunogenicity of Pegloticase (RECIPE) w/ concomitant use of MMF in pts w/ refractory gout is a phase II double blind RCT that shows sustained serum urate lowering effect in addition to decrease in monthly rate of flares. #ACRbest #Abst0952 @RheumNow Practice changing? https://t.co/Z7GwCXZftE

AR882, a Potent and Selective Uricosuric Agent, Significantly Reduced Serum Urate Levels Following Multiple Ascending Once-Daily Doses in Healthy Subject Volunteers https://t.co/fRB2zuKl5J #gout #uricosuric a novel uricosuric agent

• AR882, a Potent and Selective Uricosuric Agent, Significantly Reduced Serum Ura…

Liraglutide as a Potential Intra-Articular Treatment for Cartilage Regeneration in Osteoarthritis: In Vitro and In Vivo Studies Supporting a Pro-Chondrogenic Effect https://t.co/T9IqF7E00Z #OA #DMOAD a potential DMOAD in mice

• Liraglutide as a Potential Intra-Articular Treatment for Cartilage Regeneration…

Next up! #Autoinflammatory diseases: mechanisms and management. First: CRMO & SAPHO with Dr. Polly Ferguson Highlights: 📍The *many* names of CRMO/CNO 📍Clinical features 📍Rx options (NSAIDs, bisphosphonates, TNFi) 📍Role of innate immunity in etiology #ACRambassador https://t.co/qP3IySJKGC

Genotype analysis define new illnesses such as VEXAS. ”Somatic mutation may account for a significant fraction of adult-onset inflammatory disease” says Dr. Dan Castner. Science enthusiasm at 3S038. Autoinflammatory Diseases. @petercgrayson #ACR20 <TK https://t.co/gyTxF8NWtO

Based on RECIPE, how many of you will use MMF concomitantly with start of pegloticase in treating refractory gout patients? #ACR20 @RheumNow

@drdavidliew @VasculitisUMCG @RheumNow Dear David, thanks for your interest in our abstract #ACR20. This is based on some intriguing findings found in our previous observational study https://t.co/HKm53j2xou Still a work in progress but the potential adjunctive anti-inflammatory effect of ARBs seems attractive.

• Treatment with angiotensin II receptor blockers is associated with prolonged re…

Dr. Anthony Fauci at #ACR20 - “We are cautiously optimistic that we will have a safe and effective vaccine at the end of this calendar year and may be able to deploy in individuals with a high risk beginning in early 2021.” @RheumNow

Etanercept monotherapy significantly more effective than Methotrexate monotherapy in maintaining remission in RA patients on combination therapy. Data from the SEAM-RA study @RheumNow #ACR20 Abstr#0939 #ACRbest